{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:00:50Z","timestamp":1790629250651,"version":"4.1.0"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:sec id=\"ab-ebr250002-4\"><jats:title>Importance<\/jats:title><jats:p>Thyroid eye disease (TED) is an autoimmune disease characterized by orbital inflammation and tissue remodeling. TED pathogenesis is poorly understood but is linked to autoantibodies to thyroid-stimulating hormone receptor (TSHR) and insulinlike growth factor-1 receptor (IGF-1R).<\/jats:p><\/jats:sec><jats:sec id=\"ab-ebr250002-5\"><jats:title>Objective<\/jats:title><jats:p>To explore the potential involvement of viral infections in TED pathogenesis.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ebr250002-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>In this experimental study conducted at the Bascom Palmer Eye Institute in Miami, Florida, the National Center for Biotechnology Information Basic Local Alignment Search Tool was used to search for amino acid sequence homologies between TSHR and IGF-1R proteins to various viral proteomes, including <jats:italic>Papillomaviridae<\/jats:italic>, <jats:italic>Paramyxoviridae<\/jats:italic>, <jats:italic>Herpesviridae<\/jats:italic>, <jats:italic>Enterovirus<\/jats:italic>, <jats:italic>Polyomaviridae<\/jats:italic>, and <jats:italic>Rhabdoviridae<\/jats:italic>. Participants were enrolled from December 2021 to August 2023, with the samples tested and analyzed in September 2023. Enzyme-linked immunoassays (ELISAs) were performed on orbital adipose tissue samples from 11 participants with TED undergoing orbital decompression surgery and 11 control participants undergoing blepharoplasty to quantify antiviral antibody titers. Demographic characteristics and clinical data were reviewed.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ebr250002-7\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The main outcomes were homology analysis between TSHR and IGF-1R with several viral proteins, human papillomavirus 18 (HPV18) L1 immunoglobulin G (IgG) titers in TED orbital fat samples, and clinical characteristics associated with HPV18 L1 IgG titers.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ebr250002-8\"><jats:title>Results<\/jats:title><jats:p>Among 22 total patients, mean (range) age was 58.6 years (37.4-74.4), and 19 patients (86.4%) were female. Homology analysis revealed conserved motifs between TSHR and IGF-1R with the HPV18 L1 capsid protein. Homologous regions of FG<jats:italic>X<\/jats:italic>V and I<jats:italic>X<\/jats:italic>E<jats:italic>X<\/jats:italic>T+NP were identified across all HPV serotypes and both IGF-1R and TSHR. ELISAs showed differences in the mean HPV18 L1 IgG normalized optical density levels among tissues of controls vs participants with chronic TED (mean [<jats:italic>M<\/jats:italic>], 0.94; mean differential, \u22121.37; 95% CI, \u22122.64 to \u22120.09; <jats:italic>P<\/jats:italic>\u2009=\u2009.03), controls vs participants with acute active TED (<jats:italic>M<\/jats:italic>, 0.94; mean differential, \u22123.15; 95% CI, \u22124.69 to \u22121.61; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001), and participants with chronic TED vs acute active TED (<jats:italic>M<\/jats:italic>, 2.31; mean differential, \u22121.78; 95% CI, \u22123.44 to \u22120.13; <jats:italic>P<\/jats:italic>\u2009=\u2009.03).<\/jats:p><\/jats:sec><jats:sec id=\"ab-ebr250002-9\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This case-control study presents potential molecular evidence linking HPV and TED, highlighting molecular mimicry between HPV capsid protein and key autoimmunity targets in TED. This suggests an immunological link contributing to TED\u2019s pathogenesis, opening new potential avenues for understanding and management of the disease.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2025.0847","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T15:31:18Z","timestamp":1745508678000},"page":"524","source":"Crossref","is-referenced-by-count":4,"title":["Human Papillomavirus and Thyroid Eye Disease"],"prefix":"10.1001","volume":"143","author":[{"given":"Ishita","family":"Garg","sequence":"first","affiliation":[{"name":"Dr Nasser Ibrahim Al-Rashid Orbital Vision Research Center, McKnight Vision Research Center, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin I.","family":"Meyer","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan A.","family":"Gallo","sequence":"additional","affiliation":[{"name":"Dr Nasser Ibrahim Al-Rashid Orbital Vision Research Center, McKnight Vision Research Center, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara T.","family":"Wester","sequence":"additional","affiliation":[{"name":"Dr Nasser Ibrahim Al-Rashid Orbital Vision Research Center, McKnight Vision Research Center, University of Miami Miller School of Medicine, Miami, Florida"},{"name":"Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pelaez","sequence":"additional","affiliation":[{"name":"Dr Nasser Ibrahim Al-Rashid Orbital Vision Research Center, McKnight Vision Research Center, University of Miami Miller School of Medicine, Miami, Florida"},{"name":"Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"ebr250002r1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ecl.2021.12.004","article-title":"2022 Update on clinical management of graves disease and thyroid eye disease.","volume":"51","author":"Hoang","year":"2022","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10","key":"ebr250002r2","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1056\/NEJMcp0806317","article-title":"Clinical practice. Graves\u2019 ophthalmopathy.","volume":"360","author":"Bartalena","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"ebr250002r3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13023-017-0625-1","article-title":"Graves\u2019 orbitopathy as a rare disease in Europe: a European Group on Graves\u2019 Orbitopathy (EUGOGO) position statement.","volume":"12","author":"Perros","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"ebr250002r4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40123-019-00226-9","article-title":"Current understanding of the progression and management of thyroid associated orbitopathy: a systematic review.","volume":"9","author":"Hodgson","year":"2020","journal-title":"Ophthalmol Ther"},{"issue":"6","key":"ebr250002r5","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.3390\/microorganisms11061472","article-title":"Visiting molecular mimicry once more: pathogenicity, virulence, and autoimmunity.","volume":"11","author":"Martins","year":"2023","journal-title":"Microorganisms"},{"issue":"6","key":"ebr250002r6","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.4225","article-title":"Thyroid disease and covid-19 infection: case series.","volume":"9","author":"Allam","year":"2021","journal-title":"Clin Case Rep"},{"issue":"1","key":"ebr250002r7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.55729\/2000-9666.1287","article-title":"Reactive arthritis after mpox vaccination.","volume":"14","author":"Acharya","year":"2024","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"10","key":"ebr250002r8","doi-asserted-by":"publisher","first-page":"e2336120","DOI":"10.1001\/jamanetworkopen.2023.36120","article-title":"Autoimmune and autoinflammatory connective tissue disorders following COVID-19.","volume":"6","author":"Lim","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"ebr250002r9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3899\/jrheum.090644","article-title":"Natural history of cervical papilloma virus infection in systemic lupus erythematosus - a prospective cohort study.","volume":"37","author":"Tam","year":"2010","journal-title":"J Rheumatol"},{"issue":"3","key":"ebr250002r10","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftz028","article-title":"Human papillomavirus infection and autoimmune disorders: a tertiary center experience.","volume":"77","author":"Donmez","year":"2019","journal-title":"Pathog Dis"},{"key":"ebr250002r11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fendo.2019.00265","article-title":"Autoimmune disease in women: endocrine transition and risk across the lifespan.","volume":"10","author":"Desai","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"31","key":"ebr250002r12","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1016\/j.vaccine.2012.04.103","article-title":"An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women.","volume":"30","author":"Jacobsen","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"ebr250002r13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1365-2796.2011.02467.x","article-title":"Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine.","volume":"271","author":"Chao","year":"2012","journal-title":"J Intern Med"},{"issue":"3","key":"ebr250002r14","doi-asserted-by":"publisher","DOI":"10.4110\/in.2018.18.e19","article-title":"L1 Recombinant proteins of HPV tested for antibody forming using sera of HPV quadrivalent vaccine.","volume":"18","author":"Akuzum","year":"2018","journal-title":"Immune Netw"},{"issue":"23","key":"ebr250002r15","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1016\/j.vaccine.2019.04.049","article-title":"Human papillomavirus vaccination and the risk of autoimmune disorders: a systematic review and meta-analysis.","volume":"37","author":"Jiang","year":"2019","journal-title":"Vaccine"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2832966\/jamaophthalmology_garg_2025_br_250002_1749757343.32338.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T15:00:41Z","timestamp":1750431641000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2832966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2025.0847","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,1]]}}}